A busy day in the Senate yesterday, as Sen. Finance Chair Ron Wyden (D-OR) released some ideas about drug pricing and Senate HELP discussed vaccine hesitancy and IP protections.
First, drug pricing: Sen. Wyden released a three-page paper, Principles for Drug Pricing Reform, which says “making prescription drugs more affordable while encouraging innovation and scientific breakthroughs are not mutually exclusive.”
While the plan offers few specifics, it lays out five principles to guide potential legislation, which you can read here.
Jeanne’s Judgment: “BIO supports lowering out-of-pocket costs for patients and ensuring that all Americans have access to their prescriptions. That said, any policy that would stop innovation raises concerns, so we are reviewing Chairman Wyden’s principals and want to work productively with him.” – Jeanne Haggerty, BIO’s EVP for Advocacy
Meanwhile, during a Senate Health, Education, Labor, and Pensions (HELP) Committee hearing, there was bipartisan agreement on the need to tackle vaccine hesitancy. With 106 million Americans still unvaccinated, “we still have a ways to go to get all eligible people vaccinated and put this pandemic firmly behind us,” said Ranking Member Richard Burr (R-NC).
Identifying “vaccine ambassadors” and local leaders is key—to reach communities of color, white evangelicals, or parents, witnesses agreed.
Listen: Voices of Vaccine Hesitancy
In minority communities, addressing hesitancy requires “vaccine providers who look like, sound like, or have similar experiences and backgrounds to the vaccine recipients,” said Dr. Michelle Nichols of the Morehouse School of Medicine.
Phyllis’s Philosophy: With hundreds of Americans still dying of COVID-19 each day, we must tackle vaccine hesitancy and get more shots in arms quickly. Just as we turned to science for answers about the pandemic, we encourage everyone to turn to science for answers to questions or concerns about the vaccines. Visit www.COVIDVaccineFacts.org for scientific and evidence-based information about the vaccines—and feel confident when you and your family get your shot. – Phyllis Arthur, BIO’s VP of Infectious Diseases & Emerging Science
Oh, yes. They also discussed IP protections. “Removing the intellectual property protections only ensures that we don’t have the vaccines we need when the next pandemic occurs,” said Sen. Burr in his opening remarks. (BIO agrees.)
More Health Care News:
The New York Times: With eight million shots in a day, India tries to energize its vaccination effort
“[O]fficials say that vaccine production and procurement are being accelerated to ensure that all of India’s roughly 950 million adults are fully vaccinated by the end of the year.”